nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—ABCB1—hematologic cancer	0.136	1	CbGaD
Candesartan—PTGS1—Bortezomib—hematologic cancer	0.0399	0.0742	CbGbCtD
Candesartan—PTGS1—Thalidomide—hematologic cancer	0.0347	0.0646	CbGbCtD
Candesartan—PTGS1—Ifosfamide—hematologic cancer	0.0306	0.0569	CbGbCtD
Candesartan—PTGS1—Imatinib—hematologic cancer	0.0292	0.0544	CbGbCtD
Candesartan—CYP2C9—Bexarotene—hematologic cancer	0.0262	0.0487	CbGbCtD
Candesartan—ABCB1—Lenalidomide—hematologic cancer	0.0254	0.0473	CbGbCtD
Candesartan—CYP2C8—Bortezomib—hematologic cancer	0.023	0.0428	CbGbCtD
Candesartan—CYP2C9—Idarubicin—hematologic cancer	0.0217	0.0404	CbGbCtD
Candesartan—CYP2C8—Ifosfamide—hematologic cancer	0.0176	0.0328	CbGbCtD
Candesartan—CYP2C9—Bortezomib—hematologic cancer	0.016	0.0299	CbGbCtD
Candesartan—CYP2C8—Nilotinib—hematologic cancer	0.0153	0.0285	CbGbCtD
Candesartan—ABCB1—Daunorubicin—hematologic cancer	0.0149	0.0277	CbGbCtD
Candesartan—PTGS1—Etoposide—hematologic cancer	0.0146	0.0272	CbGbCtD
Candesartan—ABCB1—Alitretinoin—hematologic cancer	0.0146	0.0272	CbGbCtD
Candesartan—CYP2C9—Thalidomide—hematologic cancer	0.014	0.026	CbGbCtD
Candesartan—CYP2C9—Teniposide—hematologic cancer	0.0133	0.0248	CbGbCtD
Candesartan—CYP2C9—Ifosfamide—hematologic cancer	0.0123	0.0229	CbGbCtD
Candesartan—CYP2C9—Imatinib—hematologic cancer	0.0118	0.0219	CbGbCtD
Candesartan—ABCB1—Imatinib—hematologic cancer	0.0114	0.0212	CbGbCtD
Candesartan—CYP2C9—Nilotinib—hematologic cancer	0.0107	0.0199	CbGbCtD
Candesartan—ABCB1—Nilotinib—hematologic cancer	0.0104	0.0193	CbGbCtD
Candesartan—ABCB1—Vinorelbine—hematologic cancer	0.0103	0.0191	CbGbCtD
Candesartan—ABCB1—Dasatinib—hematologic cancer	0.00916	0.0171	CbGbCtD
Candesartan—ABCB1—Mitoxantrone—hematologic cancer	0.00905	0.0168	CbGbCtD
Candesartan—CYP2C8—Etoposide—hematologic cancer	0.00843	0.0157	CbGbCtD
Candesartan—ABCB1—Betamethasone—hematologic cancer	0.00807	0.015	CbGbCtD
Candesartan—ABCB1—Gemcitabine—hematologic cancer	0.00799	0.0149	CbGbCtD
Candesartan—ABCB1—Prednisolone—hematologic cancer	0.00796	0.0148	CbGbCtD
Candesartan—ABCB1—Prednisone—hematologic cancer	0.00752	0.014	CbGbCtD
Candesartan—ABCB1—Irinotecan—hematologic cancer	0.00712	0.0133	CbGbCtD
Candesartan—CYP2C8—Dexamethasone—hematologic cancer	0.00693	0.0129	CbGbCtD
Candesartan—ABCB1—Vinblastine—hematologic cancer	0.00633	0.0118	CbGbCtD
Candesartan—ABCB1—Vincristine—hematologic cancer	0.00623	0.0116	CbGbCtD
Candesartan—CYP2C9—Cisplatin—hematologic cancer	0.00598	0.0111	CbGbCtD
Candesartan—ABCB1—Cisplatin—hematologic cancer	0.00581	0.0108	CbGbCtD
Candesartan—ABCB1—Etoposide—hematologic cancer	0.00571	0.0106	CbGbCtD
Candesartan—CYP2C9—Dexamethasone—hematologic cancer	0.00483	0.009	CbGbCtD
Candesartan—ABCB1—Dexamethasone—hematologic cancer	0.00469	0.00873	CbGbCtD
Candesartan—ABCB1—Doxorubicin—hematologic cancer	0.00389	0.00724	CbGbCtD
Candesartan—ABCB1—Methotrexate—hematologic cancer	0.00377	0.00702	CbGbCtD
Candesartan—Irbesartan—JUN—hematologic cancer	0.00112	0.343	CrCbGaD
Candesartan—Pranlukast—TNF—hematologic cancer	0.000631	0.192	CrCbGaD
Candesartan—Telmisartan—ABCG2—hematologic cancer	0.00047	0.143	CrCbGaD
Candesartan—Losartan—UGT1A1—hematologic cancer	0.000434	0.132	CrCbGaD
Candesartan—AGTR1—hematopoietic system—hematologic cancer	0.000303	0.128	CbGeAlD
Candesartan—Valsartan—ALB—hematologic cancer	0.000218	0.0664	CrCbGaD
Candesartan—AGTR1—blood—hematologic cancer	0.000201	0.0851	CbGeAlD
Candesartan—Telmisartan—ABCB1—hematologic cancer	0.000195	0.0596	CrCbGaD
Candesartan—AGTR1—lung—hematologic cancer	0.000176	0.0746	CbGeAlD
Candesartan—AGTR1—testis—hematologic cancer	0.000166	0.0704	CbGeAlD
Candesartan—CYP2C8—hematopoietic system—hematologic cancer	0.000165	0.0697	CbGeAlD
Candesartan—CYP2C9—hematopoietic system—hematologic cancer	0.000146	0.0619	CbGeAlD
Candesartan—PTGS1—hematopoietic system—hematologic cancer	0.000133	0.0565	CbGeAlD
Candesartan—AGTR1—lymph node—hematologic cancer	0.000121	0.051	CbGeAlD
Candesartan—CYP2C8—blood—hematologic cancer	0.000109	0.0461	CbGeAlD
Candesartan—Losartan—ALB—hematologic cancer	0.000106	0.0324	CrCbGaD
Candesartan—Losartan—ABCB1—hematologic cancer	0.000102	0.031	CrCbGaD
Candesartan—CYP2C9—blood—hematologic cancer	9.68e-05	0.041	CbGeAlD
Candesartan—CYP2C8—testis—hematologic cancer	9.01e-05	0.0382	CbGeAlD
Candesartan—PTGS1—blood—hematologic cancer	8.84e-05	0.0374	CbGeAlD
Candesartan—ABCB1—hematopoietic system—hematologic cancer	7.89e-05	0.0334	CbGeAlD
Candesartan—PTGS1—lung—hematologic cancer	7.75e-05	0.0328	CbGeAlD
Candesartan—PTGS1—testis—hematologic cancer	7.31e-05	0.031	CbGeAlD
Candesartan—ABCB1—gonad—hematologic cancer	6e-05	0.0254	CbGeAlD
Candesartan—PTGS1—lymph node—hematologic cancer	5.3e-05	0.0224	CbGeAlD
Candesartan—ABCB1—blood—hematologic cancer	5.23e-05	0.0221	CbGeAlD
Candesartan—ABCB1—bone marrow—hematologic cancer	5.06e-05	0.0214	CbGeAlD
Candesartan—Hyperhidrosis—Dexamethasone—hematologic cancer	4.71e-05	0.000191	CcSEcCtD
Candesartan—Hyperhidrosis—Betamethasone—hematologic cancer	4.71e-05	0.000191	CcSEcCtD
Candesartan—Dizziness—Irinotecan—hematologic cancer	4.71e-05	0.000191	CcSEcCtD
Candesartan—Urticaria—Etoposide—hematologic cancer	4.71e-05	0.000191	CcSEcCtD
Candesartan—Haemoglobin—Epirubicin—hematologic cancer	4.7e-05	0.000191	CcSEcCtD
Candesartan—Rhinitis—Epirubicin—hematologic cancer	4.69e-05	0.00019	CcSEcCtD
Candesartan—Body temperature increased—Etoposide—hematologic cancer	4.68e-05	0.00019	CcSEcCtD
Candesartan—Abdominal pain—Etoposide—hematologic cancer	4.68e-05	0.00019	CcSEcCtD
Candesartan—Vertigo—Prednisone—hematologic cancer	4.68e-05	0.00019	CcSEcCtD
Candesartan—Haemorrhage—Epirubicin—hematologic cancer	4.68e-05	0.00019	CcSEcCtD
Candesartan—Hepatitis—Epirubicin—hematologic cancer	4.68e-05	0.00019	CcSEcCtD
Candesartan—Vomiting—Vincristine—hematologic cancer	4.65e-05	0.000189	CcSEcCtD
Candesartan—Urticaria—Prednisolone—hematologic cancer	4.64e-05	0.000189	CcSEcCtD
Candesartan—Asthenia—Cisplatin—hematologic cancer	4.64e-05	0.000188	CcSEcCtD
Candesartan—Pharyngitis—Epirubicin—hematologic cancer	4.64e-05	0.000188	CcSEcCtD
Candesartan—Fatigue—Triamcinolone—hematologic cancer	4.63e-05	0.000188	CcSEcCtD
Candesartan—Urinary tract disorder—Epirubicin—hematologic cancer	4.62e-05	0.000188	CcSEcCtD
Candesartan—Rash—Vincristine—hematologic cancer	4.61e-05	0.000187	CcSEcCtD
Candesartan—Dermatitis—Vincristine—hematologic cancer	4.61e-05	0.000187	CcSEcCtD
Candesartan—Oedema peripheral—Epirubicin—hematologic cancer	4.61e-05	0.000187	CcSEcCtD
Candesartan—Haematuria—Doxorubicin—hematologic cancer	4.59e-05	0.000187	CcSEcCtD
Candesartan—Urethral disorder—Epirubicin—hematologic cancer	4.58e-05	0.000186	CcSEcCtD
Candesartan—Headache—Vincristine—hematologic cancer	4.58e-05	0.000186	CcSEcCtD
Candesartan—ABCB1—lung—hematologic cancer	4.58e-05	0.0194	CbGeAlD
Candesartan—Hypotension—Betamethasone—hematologic cancer	4.56e-05	0.000185	CcSEcCtD
Candesartan—Hypotension—Dexamethasone—hematologic cancer	4.56e-05	0.000185	CcSEcCtD
Candesartan—Nausea—Carmustine—hematologic cancer	4.55e-05	0.000185	CcSEcCtD
Candesartan—Epistaxis—Doxorubicin—hematologic cancer	4.55e-05	0.000185	CcSEcCtD
Candesartan—Vomiting—Irinotecan—hematologic cancer	4.53e-05	0.000184	CcSEcCtD
Candesartan—Vomiting—Mitoxantrone—hematologic cancer	4.53e-05	0.000184	CcSEcCtD
Candesartan—Sinusitis—Doxorubicin—hematologic cancer	4.52e-05	0.000184	CcSEcCtD
Candesartan—Nausea—Alitretinoin—hematologic cancer	4.51e-05	0.000183	CcSEcCtD
Candesartan—Agranulocytosis—Doxorubicin—hematologic cancer	4.5e-05	0.000183	CcSEcCtD
Candesartan—Hypertension—Prednisone—hematologic cancer	4.49e-05	0.000182	CcSEcCtD
Candesartan—Rash—Mitoxantrone—hematologic cancer	4.49e-05	0.000182	CcSEcCtD
Candesartan—Rash—Irinotecan—hematologic cancer	4.49e-05	0.000182	CcSEcCtD
Candesartan—Dermatitis—Irinotecan—hematologic cancer	4.49e-05	0.000182	CcSEcCtD
Candesartan—Dermatitis—Mitoxantrone—hematologic cancer	4.49e-05	0.000182	CcSEcCtD
Candesartan—Headache—Irinotecan—hematologic cancer	4.46e-05	0.000181	CcSEcCtD
Candesartan—Headache—Mitoxantrone—hematologic cancer	4.46e-05	0.000181	CcSEcCtD
Candesartan—Nausea—Ifosfamide—hematologic cancer	4.46e-05	0.000181	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.44e-05	0.00018	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.44e-05	0.00018	CcSEcCtD
Candesartan—Arthralgia—Prednisone—hematologic cancer	4.43e-05	0.00018	CcSEcCtD
Candesartan—Myalgia—Prednisone—hematologic cancer	4.43e-05	0.00018	CcSEcCtD
Candesartan—Diarrhoea—Cisplatin—hematologic cancer	4.43e-05	0.00018	CcSEcCtD
Candesartan—Anxiety—Prednisone—hematologic cancer	4.41e-05	0.000179	CcSEcCtD
Candesartan—Vomiting—Gemcitabine—hematologic cancer	4.41e-05	0.000179	CcSEcCtD
Candesartan—Paraesthesia—Dexamethasone—hematologic cancer	4.38e-05	0.000178	CcSEcCtD
Candesartan—Paraesthesia—Betamethasone—hematologic cancer	4.38e-05	0.000178	CcSEcCtD
Candesartan—Mental disorder—Methotrexate—hematologic cancer	4.38e-05	0.000178	CcSEcCtD
Candesartan—Rash—Gemcitabine—hematologic cancer	4.38e-05	0.000178	CcSEcCtD
Candesartan—Dermatitis—Gemcitabine—hematologic cancer	4.37e-05	0.000178	CcSEcCtD
Candesartan—Malnutrition—Methotrexate—hematologic cancer	4.35e-05	0.000177	CcSEcCtD
Candesartan—Haemoglobin—Doxorubicin—hematologic cancer	4.35e-05	0.000177	CcSEcCtD
Candesartan—Headache—Gemcitabine—hematologic cancer	4.35e-05	0.000177	CcSEcCtD
Candesartan—Nausea—Vincristine—hematologic cancer	4.34e-05	0.000176	CcSEcCtD
Candesartan—Rhinitis—Doxorubicin—hematologic cancer	4.34e-05	0.000176	CcSEcCtD
Candesartan—Hepatitis—Doxorubicin—hematologic cancer	4.33e-05	0.000176	CcSEcCtD
Candesartan—Haemorrhage—Doxorubicin—hematologic cancer	4.33e-05	0.000176	CcSEcCtD
Candesartan—ABCB1—testis—hematologic cancer	4.32e-05	0.0183	CbGeAlD
Candesartan—Pharyngitis—Doxorubicin—hematologic cancer	4.29e-05	0.000174	CcSEcCtD
Candesartan—Dyspepsia—Betamethasone—hematologic cancer	4.29e-05	0.000174	CcSEcCtD
Candesartan—Dyspepsia—Dexamethasone—hematologic cancer	4.29e-05	0.000174	CcSEcCtD
Candesartan—Urinary tract disorder—Doxorubicin—hematologic cancer	4.27e-05	0.000174	CcSEcCtD
Candesartan—Urticaria—Triamcinolone—hematologic cancer	4.27e-05	0.000173	CcSEcCtD
Candesartan—Oedema peripheral—Doxorubicin—hematologic cancer	4.26e-05	0.000173	CcSEcCtD
Candesartan—Asthenia—Etoposide—hematologic cancer	4.25e-05	0.000173	CcSEcCtD
Candesartan—Body temperature increased—Triamcinolone—hematologic cancer	4.25e-05	0.000173	CcSEcCtD
Candesartan—Urethral disorder—Doxorubicin—hematologic cancer	4.24e-05	0.000172	CcSEcCtD
Candesartan—Nausea—Mitoxantrone—hematologic cancer	4.23e-05	0.000172	CcSEcCtD
Candesartan—Nausea—Irinotecan—hematologic cancer	4.23e-05	0.000172	CcSEcCtD
Candesartan—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.21e-05	0.000171	CcSEcCtD
Candesartan—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.21e-05	0.000171	CcSEcCtD
Candesartan—Back pain—Methotrexate—hematologic cancer	4.21e-05	0.000171	CcSEcCtD
Candesartan—Fatigue—Dexamethasone—hematologic cancer	4.2e-05	0.000171	CcSEcCtD
Candesartan—Fatigue—Betamethasone—hematologic cancer	4.2e-05	0.000171	CcSEcCtD
Candesartan—Pruritus—Etoposide—hematologic cancer	4.19e-05	0.00017	CcSEcCtD
Candesartan—Tachycardia—Prednisone—hematologic cancer	4.14e-05	0.000168	CcSEcCtD
Candesartan—Nausea—Gemcitabine—hematologic cancer	4.12e-05	0.000167	CcSEcCtD
Candesartan—Vomiting—Cisplatin—hematologic cancer	4.11e-05	0.000167	CcSEcCtD
Candesartan—Hyperhidrosis—Prednisone—hematologic cancer	4.11e-05	0.000167	CcSEcCtD
Candesartan—Mental disorder—Epirubicin—hematologic cancer	4.1e-05	0.000166	CcSEcCtD
Candesartan—Rash—Cisplatin—hematologic cancer	4.08e-05	0.000166	CcSEcCtD
Candesartan—Dermatitis—Cisplatin—hematologic cancer	4.07e-05	0.000165	CcSEcCtD
Candesartan—Malnutrition—Epirubicin—hematologic cancer	4.07e-05	0.000165	CcSEcCtD
Candesartan—Diarrhoea—Etoposide—hematologic cancer	4.05e-05	0.000165	CcSEcCtD
Candesartan—Anaemia—Methotrexate—hematologic cancer	4.02e-05	0.000163	CcSEcCtD
Candesartan—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.99e-05	0.000162	CcSEcCtD
Candesartan—Gastrointestinal pain—Betamethasone—hematologic cancer	3.99e-05	0.000162	CcSEcCtD
Candesartan—Back pain—Epirubicin—hematologic cancer	3.94e-05	0.00016	CcSEcCtD
Candesartan—Dizziness—Etoposide—hematologic cancer	3.92e-05	0.000159	CcSEcCtD
Candesartan—Vertigo—Methotrexate—hematologic cancer	3.91e-05	0.000159	CcSEcCtD
Candesartan—Leukopenia—Methotrexate—hematologic cancer	3.89e-05	0.000158	CcSEcCtD
Candesartan—Urticaria—Betamethasone—hematologic cancer	3.87e-05	0.000157	CcSEcCtD
Candesartan—Urticaria—Dexamethasone—hematologic cancer	3.87e-05	0.000157	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.87e-05	0.000157	CcSEcCtD
Candesartan—Dizziness—Prednisolone—hematologic cancer	3.86e-05	0.000157	CcSEcCtD
Candesartan—Asthenia—Triamcinolone—hematologic cancer	3.86e-05	0.000157	CcSEcCtD
Candesartan—Body temperature increased—Betamethasone—hematologic cancer	3.86e-05	0.000157	CcSEcCtD
Candesartan—Body temperature increased—Dexamethasone—hematologic cancer	3.86e-05	0.000157	CcSEcCtD
Candesartan—Abdominal pain—Betamethasone—hematologic cancer	3.86e-05	0.000157	CcSEcCtD
Candesartan—Abdominal pain—Dexamethasone—hematologic cancer	3.86e-05	0.000157	CcSEcCtD
Candesartan—Nausea—Cisplatin—hematologic cancer	3.84e-05	0.000156	CcSEcCtD
Candesartan—Paraesthesia—Prednisone—hematologic cancer	3.81e-05	0.000155	CcSEcCtD
Candesartan—Pruritus—Triamcinolone—hematologic cancer	3.8e-05	0.000154	CcSEcCtD
Candesartan—Cough—Methotrexate—hematologic cancer	3.79e-05	0.000154	CcSEcCtD
Candesartan—Mental disorder—Doxorubicin—hematologic cancer	3.79e-05	0.000154	CcSEcCtD
Candesartan—Vomiting—Etoposide—hematologic cancer	3.77e-05	0.000153	CcSEcCtD
Candesartan—Malnutrition—Doxorubicin—hematologic cancer	3.77e-05	0.000153	CcSEcCtD
Candesartan—Anaemia—Epirubicin—hematologic cancer	3.76e-05	0.000153	CcSEcCtD
Candesartan—Dyspepsia—Prednisone—hematologic cancer	3.74e-05	0.000152	CcSEcCtD
Candesartan—Rash—Etoposide—hematologic cancer	3.74e-05	0.000152	CcSEcCtD
Candesartan—Dermatitis—Etoposide—hematologic cancer	3.73e-05	0.000152	CcSEcCtD
Candesartan—Headache—Etoposide—hematologic cancer	3.71e-05	0.000151	CcSEcCtD
Candesartan—Chest pain—Methotrexate—hematologic cancer	3.7e-05	0.00015	CcSEcCtD
Candesartan—Myalgia—Methotrexate—hematologic cancer	3.7e-05	0.00015	CcSEcCtD
Candesartan—Arthralgia—Methotrexate—hematologic cancer	3.7e-05	0.00015	CcSEcCtD
Candesartan—Rash—Prednisolone—hematologic cancer	3.68e-05	0.00015	CcSEcCtD
Candesartan—Dermatitis—Prednisolone—hematologic cancer	3.68e-05	0.00015	CcSEcCtD
Candesartan—Fatigue—Prednisone—hematologic cancer	3.66e-05	0.000149	CcSEcCtD
Candesartan—Headache—Prednisolone—hematologic cancer	3.66e-05	0.000149	CcSEcCtD
Candesartan—Vertigo—Epirubicin—hematologic cancer	3.66e-05	0.000149	CcSEcCtD
Candesartan—Leukopenia—Epirubicin—hematologic cancer	3.64e-05	0.000148	CcSEcCtD
Candesartan—Back pain—Doxorubicin—hematologic cancer	3.64e-05	0.000148	CcSEcCtD
Candesartan—Palpitations—Epirubicin—hematologic cancer	3.6e-05	0.000146	CcSEcCtD
Candesartan—Dizziness—Triamcinolone—hematologic cancer	3.55e-05	0.000144	CcSEcCtD
Candesartan—Cough—Epirubicin—hematologic cancer	3.55e-05	0.000144	CcSEcCtD
Candesartan—Nausea—Etoposide—hematologic cancer	3.52e-05	0.000143	CcSEcCtD
Candesartan—Hypertension—Epirubicin—hematologic cancer	3.51e-05	0.000143	CcSEcCtD
Candesartan—Asthenia—Dexamethasone—hematologic cancer	3.5e-05	0.000142	CcSEcCtD
Candesartan—Asthenia—Betamethasone—hematologic cancer	3.5e-05	0.000142	CcSEcCtD
Candesartan—Anaemia—Doxorubicin—hematologic cancer	3.48e-05	0.000141	CcSEcCtD
Candesartan—Thrombocytopenia—Methotrexate—hematologic cancer	3.48e-05	0.000141	CcSEcCtD
Candesartan—Gastrointestinal pain—Prednisone—hematologic cancer	3.47e-05	0.000141	CcSEcCtD
Candesartan—Nausea—Prednisolone—hematologic cancer	3.47e-05	0.000141	CcSEcCtD
Candesartan—Arthralgia—Epirubicin—hematologic cancer	3.46e-05	0.000141	CcSEcCtD
Candesartan—Myalgia—Epirubicin—hematologic cancer	3.46e-05	0.000141	CcSEcCtD
Candesartan—Chest pain—Epirubicin—hematologic cancer	3.46e-05	0.000141	CcSEcCtD
Candesartan—Anxiety—Epirubicin—hematologic cancer	3.45e-05	0.00014	CcSEcCtD
Candesartan—Pruritus—Betamethasone—hematologic cancer	3.45e-05	0.00014	CcSEcCtD
Candesartan—Pruritus—Dexamethasone—hematologic cancer	3.45e-05	0.00014	CcSEcCtD
Candesartan—Hyperhidrosis—Methotrexate—hematologic cancer	3.43e-05	0.000139	CcSEcCtD
Candesartan—Vomiting—Triamcinolone—hematologic cancer	3.42e-05	0.000139	CcSEcCtD
Candesartan—Rash—Triamcinolone—hematologic cancer	3.39e-05	0.000138	CcSEcCtD
Candesartan—Dermatitis—Triamcinolone—hematologic cancer	3.39e-05	0.000138	CcSEcCtD
Candesartan—Vertigo—Doxorubicin—hematologic cancer	3.38e-05	0.000137	CcSEcCtD
Candesartan—Urticaria—Prednisone—hematologic cancer	3.37e-05	0.000137	CcSEcCtD
Candesartan—Leukopenia—Doxorubicin—hematologic cancer	3.37e-05	0.000137	CcSEcCtD
Candesartan—Headache—Triamcinolone—hematologic cancer	3.37e-05	0.000137	CcSEcCtD
Candesartan—Body temperature increased—Prednisone—hematologic cancer	3.36e-05	0.000136	CcSEcCtD
Candesartan—Abdominal pain—Prednisone—hematologic cancer	3.36e-05	0.000136	CcSEcCtD
Candesartan—Diarrhoea—Dexamethasone—hematologic cancer	3.34e-05	0.000136	CcSEcCtD
Candesartan—Diarrhoea—Betamethasone—hematologic cancer	3.34e-05	0.000136	CcSEcCtD
Candesartan—Palpitations—Doxorubicin—hematologic cancer	3.33e-05	0.000135	CcSEcCtD
Candesartan—Hypotension—Methotrexate—hematologic cancer	3.32e-05	0.000135	CcSEcCtD
Candesartan—Cough—Doxorubicin—hematologic cancer	3.29e-05	0.000133	CcSEcCtD
Candesartan—Thrombocytopenia—Epirubicin—hematologic cancer	3.25e-05	0.000132	CcSEcCtD
Candesartan—Hypertension—Doxorubicin—hematologic cancer	3.25e-05	0.000132	CcSEcCtD
Candesartan—Tachycardia—Epirubicin—hematologic cancer	3.24e-05	0.000132	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.23e-05	0.000131	CcSEcCtD
Candesartan—Dizziness—Dexamethasone—hematologic cancer	3.22e-05	0.000131	CcSEcCtD
Candesartan—Dizziness—Betamethasone—hematologic cancer	3.22e-05	0.000131	CcSEcCtD
Candesartan—Hyperhidrosis—Epirubicin—hematologic cancer	3.21e-05	0.00013	CcSEcCtD
Candesartan—Myalgia—Doxorubicin—hematologic cancer	3.21e-05	0.00013	CcSEcCtD
Candesartan—Chest pain—Doxorubicin—hematologic cancer	3.21e-05	0.00013	CcSEcCtD
Candesartan—Arthralgia—Doxorubicin—hematologic cancer	3.21e-05	0.00013	CcSEcCtD
Candesartan—Anxiety—Doxorubicin—hematologic cancer	3.19e-05	0.00013	CcSEcCtD
Candesartan—Nausea—Triamcinolone—hematologic cancer	3.19e-05	0.00013	CcSEcCtD
Candesartan—Paraesthesia—Methotrexate—hematologic cancer	3.19e-05	0.000129	CcSEcCtD
Candesartan—Dyspnoea—Methotrexate—hematologic cancer	3.16e-05	0.000129	CcSEcCtD
Candesartan—Somnolence—Methotrexate—hematologic cancer	3.16e-05	0.000128	CcSEcCtD
Candesartan—ABCB1—lymph node—hematologic cancer	3.13e-05	0.0133	CbGeAlD
Candesartan—Dyspepsia—Methotrexate—hematologic cancer	3.12e-05	0.000127	CcSEcCtD
Candesartan—Hypotension—Epirubicin—hematologic cancer	3.1e-05	0.000126	CcSEcCtD
Candesartan—Vomiting—Betamethasone—hematologic cancer	3.1e-05	0.000126	CcSEcCtD
Candesartan—Vomiting—Dexamethasone—hematologic cancer	3.1e-05	0.000126	CcSEcCtD
Candesartan—Rash—Dexamethasone—hematologic cancer	3.07e-05	0.000125	CcSEcCtD
Candesartan—Rash—Betamethasone—hematologic cancer	3.07e-05	0.000125	CcSEcCtD
Candesartan—Dermatitis—Dexamethasone—hematologic cancer	3.07e-05	0.000125	CcSEcCtD
Candesartan—Dermatitis—Betamethasone—hematologic cancer	3.07e-05	0.000125	CcSEcCtD
Candesartan—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.06e-05	0.000124	CcSEcCtD
Candesartan—Fatigue—Methotrexate—hematologic cancer	3.06e-05	0.000124	CcSEcCtD
Candesartan—Headache—Betamethasone—hematologic cancer	3.06e-05	0.000124	CcSEcCtD
Candesartan—Headache—Dexamethasone—hematologic cancer	3.06e-05	0.000124	CcSEcCtD
Candesartan—Asthenia—Prednisone—hematologic cancer	3.05e-05	0.000124	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.03e-05	0.000123	CcSEcCtD
Candesartan—Thrombocytopenia—Doxorubicin—hematologic cancer	3.01e-05	0.000122	CcSEcCtD
Candesartan—Pruritus—Prednisone—hematologic cancer	3e-05	0.000122	CcSEcCtD
Candesartan—Tachycardia—Doxorubicin—hematologic cancer	3e-05	0.000122	CcSEcCtD
Candesartan—Paraesthesia—Epirubicin—hematologic cancer	2.98e-05	0.000121	CcSEcCtD
Candesartan—Hyperhidrosis—Doxorubicin—hematologic cancer	2.97e-05	0.000121	CcSEcCtD
Candesartan—Dyspnoea—Epirubicin—hematologic cancer	2.96e-05	0.00012	CcSEcCtD
Candesartan—Somnolence—Epirubicin—hematologic cancer	2.95e-05	0.00012	CcSEcCtD
Candesartan—Dyspepsia—Epirubicin—hematologic cancer	2.92e-05	0.000119	CcSEcCtD
Candesartan—Diarrhoea—Prednisone—hematologic cancer	2.91e-05	0.000118	CcSEcCtD
Candesartan—Gastrointestinal pain—Methotrexate—hematologic cancer	2.9e-05	0.000118	CcSEcCtD
Candesartan—Nausea—Betamethasone—hematologic cancer	2.9e-05	0.000118	CcSEcCtD
Candesartan—Nausea—Dexamethasone—hematologic cancer	2.9e-05	0.000118	CcSEcCtD
Candesartan—Hypotension—Doxorubicin—hematologic cancer	2.87e-05	0.000117	CcSEcCtD
Candesartan—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.87e-05	0.000116	CcSEcCtD
Candesartan—Fatigue—Epirubicin—hematologic cancer	2.86e-05	0.000116	CcSEcCtD
Candesartan—Urticaria—Methotrexate—hematologic cancer	2.82e-05	0.000115	CcSEcCtD
Candesartan—Dizziness—Prednisone—hematologic cancer	2.81e-05	0.000114	CcSEcCtD
Candesartan—Abdominal pain—Methotrexate—hematologic cancer	2.81e-05	0.000114	CcSEcCtD
Candesartan—Body temperature increased—Methotrexate—hematologic cancer	2.81e-05	0.000114	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.8e-05	0.000114	CcSEcCtD
Candesartan—Paraesthesia—Doxorubicin—hematologic cancer	2.76e-05	0.000112	CcSEcCtD
Candesartan—Dyspnoea—Doxorubicin—hematologic cancer	2.74e-05	0.000111	CcSEcCtD
Candesartan—Somnolence—Doxorubicin—hematologic cancer	2.73e-05	0.000111	CcSEcCtD
Candesartan—Gastrointestinal pain—Epirubicin—hematologic cancer	2.72e-05	0.00011	CcSEcCtD
Candesartan—Dyspepsia—Doxorubicin—hematologic cancer	2.71e-05	0.00011	CcSEcCtD
Candesartan—Vomiting—Prednisone—hematologic cancer	2.7e-05	0.00011	CcSEcCtD
Candesartan—Rash—Prednisone—hematologic cancer	2.68e-05	0.000109	CcSEcCtD
Candesartan—Dermatitis—Prednisone—hematologic cancer	2.68e-05	0.000109	CcSEcCtD
Candesartan—Headache—Prednisone—hematologic cancer	2.66e-05	0.000108	CcSEcCtD
Candesartan—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.65e-05	0.000108	CcSEcCtD
Candesartan—Fatigue—Doxorubicin—hematologic cancer	2.65e-05	0.000108	CcSEcCtD
Candesartan—Urticaria—Epirubicin—hematologic cancer	2.64e-05	0.000107	CcSEcCtD
Candesartan—Body temperature increased—Epirubicin—hematologic cancer	2.63e-05	0.000107	CcSEcCtD
Candesartan—Abdominal pain—Epirubicin—hematologic cancer	2.63e-05	0.000107	CcSEcCtD
Candesartan—Asthenia—Methotrexate—hematologic cancer	2.55e-05	0.000103	CcSEcCtD
Candesartan—Nausea—Prednisone—hematologic cancer	2.52e-05	0.000102	CcSEcCtD
Candesartan—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.51e-05	0.000102	CcSEcCtD
Candesartan—Pruritus—Methotrexate—hematologic cancer	2.51e-05	0.000102	CcSEcCtD
Candesartan—Urticaria—Doxorubicin—hematologic cancer	2.44e-05	9.92e-05	CcSEcCtD
Candesartan—Body temperature increased—Doxorubicin—hematologic cancer	2.43e-05	9.87e-05	CcSEcCtD
Candesartan—Abdominal pain—Doxorubicin—hematologic cancer	2.43e-05	9.87e-05	CcSEcCtD
Candesartan—Diarrhoea—Methotrexate—hematologic cancer	2.43e-05	9.86e-05	CcSEcCtD
Candesartan—Asthenia—Epirubicin—hematologic cancer	2.38e-05	9.68e-05	CcSEcCtD
Candesartan—Pruritus—Epirubicin—hematologic cancer	2.35e-05	9.54e-05	CcSEcCtD
Candesartan—Dizziness—Methotrexate—hematologic cancer	2.35e-05	9.53e-05	CcSEcCtD
Candesartan—Diarrhoea—Epirubicin—hematologic cancer	2.27e-05	9.23e-05	CcSEcCtD
Candesartan—Vomiting—Methotrexate—hematologic cancer	2.26e-05	9.17e-05	CcSEcCtD
Candesartan—Rash—Methotrexate—hematologic cancer	2.24e-05	9.09e-05	CcSEcCtD
Candesartan—Dermatitis—Methotrexate—hematologic cancer	2.24e-05	9.08e-05	CcSEcCtD
Candesartan—Headache—Methotrexate—hematologic cancer	2.22e-05	9.03e-05	CcSEcCtD
Candesartan—Asthenia—Doxorubicin—hematologic cancer	2.21e-05	8.96e-05	CcSEcCtD
Candesartan—Dizziness—Epirubicin—hematologic cancer	2.2e-05	8.92e-05	CcSEcCtD
Candesartan—Pruritus—Doxorubicin—hematologic cancer	2.17e-05	8.83e-05	CcSEcCtD
Candesartan—Vomiting—Epirubicin—hematologic cancer	2.11e-05	8.58e-05	CcSEcCtD
Candesartan—Nausea—Methotrexate—hematologic cancer	2.11e-05	8.56e-05	CcSEcCtD
Candesartan—Diarrhoea—Doxorubicin—hematologic cancer	2.1e-05	8.54e-05	CcSEcCtD
Candesartan—Rash—Epirubicin—hematologic cancer	2.09e-05	8.51e-05	CcSEcCtD
Candesartan—Dermatitis—Epirubicin—hematologic cancer	2.09e-05	8.5e-05	CcSEcCtD
Candesartan—Headache—Epirubicin—hematologic cancer	2.08e-05	8.45e-05	CcSEcCtD
Candesartan—Dizziness—Doxorubicin—hematologic cancer	2.03e-05	8.25e-05	CcSEcCtD
Candesartan—Nausea—Epirubicin—hematologic cancer	1.97e-05	8.01e-05	CcSEcCtD
Candesartan—Vomiting—Doxorubicin—hematologic cancer	1.95e-05	7.94e-05	CcSEcCtD
Candesartan—Rash—Doxorubicin—hematologic cancer	1.94e-05	7.87e-05	CcSEcCtD
Candesartan—Dermatitis—Doxorubicin—hematologic cancer	1.94e-05	7.86e-05	CcSEcCtD
Candesartan—Headache—Doxorubicin—hematologic cancer	1.93e-05	7.82e-05	CcSEcCtD
Candesartan—Nausea—Doxorubicin—hematologic cancer	1.83e-05	7.41e-05	CcSEcCtD
Candesartan—AGTR1—Signaling Pathways—TERT—hematologic cancer	1.18e-05	0.000158	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ACP5—hematologic cancer	1.18e-05	0.000157	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CA9—hematologic cancer	1.18e-05	0.000157	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NCOR2—hematologic cancer	1.16e-05	0.000155	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.16e-05	0.000155	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.16e-05	0.000154	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PDGFB—hematologic cancer	1.16e-05	0.000154	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TSC2—hematologic cancer	1.13e-05	0.000151	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—FHL2—hematologic cancer	1.13e-05	0.00015	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.13e-05	0.00015	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMMR—hematologic cancer	1.12e-05	0.00015	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—IDH2—hematologic cancer	1.12e-05	0.00015	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—IDH1—hematologic cancer	1.11e-05	0.000148	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGRN—hematologic cancer	1.11e-05	0.000147	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CG—hematologic cancer	1.11e-05	0.000147	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTO1—hematologic cancer	1.1e-05	0.000146	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCC3—hematologic cancer	1.1e-05	0.000146	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TXN—hematologic cancer	1.1e-05	0.000146	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CD44—hematologic cancer	1.09e-05	0.000146	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NQO1—hematologic cancer	1.09e-05	0.000146	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGFR3—hematologic cancer	1.09e-05	0.000145	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK14—hematologic cancer	1.08e-05	0.000143	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SPHK1—hematologic cancer	1.07e-05	0.000143	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.07e-05	0.000143	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.07e-05	0.000142	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ARNTL—hematologic cancer	1.06e-05	0.000141	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ESR1—hematologic cancer	1.06e-05	0.000141	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMMR—hematologic cancer	1.05e-05	0.00014	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—IDH2—hematologic cancer	1.05e-05	0.00014	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FN1—hematologic cancer	1.04e-05	0.000139	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.04e-05	0.000138	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYCS—hematologic cancer	1.04e-05	0.000138	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.03e-05	0.000138	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—UGT1A1—hematologic cancer	1.03e-05	0.000137	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFKBIA—hematologic cancer	1.03e-05	0.000137	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BAD—hematologic cancer	1.03e-05	0.000137	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HSP90AA1—hematologic cancer	1.03e-05	0.000137	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CA9—hematologic cancer	1.03e-05	0.000137	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ACP5—hematologic cancer	1.03e-05	0.000137	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CREBBP—hematologic cancer	1.02e-05	0.000137	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOTCH1—hematologic cancer	1.02e-05	0.000136	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NCOR2—hematologic cancer	1.01e-05	0.000135	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC22A1—hematologic cancer	1e-05	0.000134	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CRABP1—hematologic cancer	1e-05	0.000134	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CD80—hematologic cancer	1e-05	0.000133	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KIT—hematologic cancer	9.98e-06	0.000133	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CG—hematologic cancer	9.98e-06	0.000133	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—NRAS—hematologic cancer	9.98e-06	0.000133	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.9e-06	0.000132	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ARNTL—hematologic cancer	9.87e-06	0.000131	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTPN11—hematologic cancer	9.81e-06	0.000131	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALOX5—hematologic cancer	9.77e-06	0.00013	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CD—hematologic cancer	9.72e-06	0.000129	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—IDH1—hematologic cancer	9.66e-06	0.000129	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	9.66e-06	0.000129	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ACP5—hematologic cancer	9.6e-06	0.000128	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CA9—hematologic cancer	9.6e-06	0.000128	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—hematologic cancer	9.59e-06	0.000128	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	9.58e-06	0.000128	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK3—hematologic cancer	9.56e-06	0.000127	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TXN—hematologic cancer	9.55e-06	0.000127	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTO1—hematologic cancer	9.55e-06	0.000127	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCC3—hematologic cancer	9.55e-06	0.000127	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CREB1—hematologic cancer	9.5e-06	0.000127	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NCOR2—hematologic cancer	9.48e-06	0.000126	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NUP98—hematologic cancer	9.47e-06	0.000126	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—BRAF—hematologic cancer	9.38e-06	0.000125	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SPHK1—hematologic cancer	9.35e-06	0.000125	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL2—hematologic cancer	9.3e-06	0.000124	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6R—hematologic cancer	9.27e-06	0.000123	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.26e-06	0.000123	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CREBBP—hematologic cancer	9.26e-06	0.000123	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ADCY7—hematologic cancer	9.19e-06	0.000122	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NCOA3—hematologic cancer	9.19e-06	0.000122	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3R1—hematologic cancer	9.18e-06	0.000122	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NUP214—hematologic cancer	9.13e-06	0.000122	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTP1—hematologic cancer	9.12e-06	0.000122	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.03e-06	0.00012	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—IDH1—hematologic cancer	9.03e-06	0.00012	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—UGT1A1—hematologic cancer	8.98e-06	0.00012	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTR—hematologic cancer	8.94e-06	0.000119	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCG2—hematologic cancer	8.94e-06	0.000119	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTO1—hematologic cancer	8.93e-06	0.000119	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCC3—hematologic cancer	8.93e-06	0.000119	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TXN—hematologic cancer	8.93e-06	0.000119	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAP2K1—hematologic cancer	8.83e-06	0.000118	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.83e-06	0.000118	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	8.8e-06	0.000117	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CD—hematologic cancer	8.78e-06	0.000117	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ENO2—hematologic cancer	8.77e-06	0.000117	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC22A1—hematologic cancer	8.74e-06	0.000116	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CRABP1—hematologic cancer	8.74e-06	0.000116	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SPHK1—hematologic cancer	8.73e-06	0.000116	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—PIK3CA—hematologic cancer	8.69e-06	0.000116	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCB1—hematologic cancer	8.64e-06	0.000115	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—KRAS—hematologic cancer	8.59e-06	0.000114	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALOX5—hematologic cancer	8.52e-06	0.000113	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	8.51e-06	0.000113	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTT1—hematologic cancer	8.5e-06	0.000113	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CB—hematologic cancer	8.47e-06	0.000113	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGF2—hematologic cancer	8.4e-06	0.000112	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—UGT1A1—hematologic cancer	8.39e-06	0.000112	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—hematologic cancer	8.39e-06	0.000112	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NCOR1—hematologic cancer	8.39e-06	0.000112	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.37e-06	0.000112	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SDC1—hematologic cancer	8.31e-06	0.000111	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3R1—hematologic cancer	8.29e-06	0.00011	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NUP98—hematologic cancer	8.25e-06	0.00011	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC22A1—hematologic cancer	8.16e-06	0.000109	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CRABP1—hematologic cancer	8.16e-06	0.000109	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JAK2—hematologic cancer	8.05e-06	0.000107	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ADCY7—hematologic cancer	8.01e-06	0.000107	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NCOA3—hematologic cancer	8.01e-06	0.000107	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.96e-06	0.000106	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NUP214—hematologic cancer	7.95e-06	0.000106	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.94e-06	0.000106	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PIK3CA—hematologic cancer	7.89e-06	0.000105	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MDM2—hematologic cancer	7.86e-06	0.000105	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.84e-06	0.000104	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTR—hematologic cancer	7.79e-06	0.000104	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCG2—hematologic cancer	7.79e-06	0.000104	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NUP98—hematologic cancer	7.7e-06	0.000103	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MTOR—hematologic cancer	7.65e-06	0.000102	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CB—hematologic cancer	7.65e-06	0.000102	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ENO2—hematologic cancer	7.64e-06	0.000102	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.5e-06	9.99e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ADCY7—hematologic cancer	7.48e-06	9.96e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NCOA3—hematologic cancer	7.48e-06	9.96e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NUP214—hematologic cancer	7.43e-06	9.89e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—hematologic cancer	7.41e-06	9.87e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTT1—hematologic cancer	7.41e-06	9.87e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.35e-06	9.79e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTEN—hematologic cancer	7.32e-06	9.75e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—HRAS—hematologic cancer	7.3e-06	9.73e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTR—hematologic cancer	7.28e-06	9.69e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCG2—hematologic cancer	7.28e-06	9.69e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SDC1—hematologic cancer	7.24e-06	9.64e-05	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	7.19e-06	9.58e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1B—hematologic cancer	7.18e-06	9.56e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ENO2—hematologic cancer	7.14e-06	9.5e-05	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—hematologic cancer	7.1e-06	9.46e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NQO1—hematologic cancer	7.07e-06	9.41e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CD44—hematologic cancer	7.07e-06	9.41e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CASP3—hematologic cancer	7.04e-06	9.37e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—hematologic cancer	7.02e-06	9.36e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—hematologic cancer	6.99e-06	9.31e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—EP300—hematologic cancer	6.98e-06	9.3e-05	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.94e-06	9.24e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.92e-06	9.22e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.92e-06	9.22e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—hematologic cancer	6.85e-06	9.12e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JUN—hematologic cancer	6.83e-06	9.1e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.81e-06	9.08e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SDC1—hematologic cancer	6.76e-06	9.01e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYCS—hematologic cancer	6.69e-06	8.91e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	6.64e-06	8.85e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1A—hematologic cancer	6.62e-06	8.82e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTEN—hematologic cancer	6.61e-06	8.8e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.53e-06	8.7e-05	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	6.49e-06	8.65e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK8—hematologic cancer	6.47e-06	8.61e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.46e-06	8.61e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—hematologic cancer	6.45e-06	8.59e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.38e-06	8.5e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EP300—hematologic cancer	6.3e-06	8.4e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CG—hematologic cancer	6.23e-06	8.29e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CD44—hematologic cancer	6.16e-06	8.2e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NQO1—hematologic cancer	6.16e-06	8.2e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SRC—hematologic cancer	6.13e-06	8.16e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.1e-06	8.13e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.98e-06	7.96e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—hematologic cancer	5.97e-06	7.95e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—hematologic cancer	5.91e-06	7.87e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NRAS—hematologic cancer	5.9e-06	7.85e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTP1—hematologic cancer	5.89e-06	7.85e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYCS—hematologic cancer	5.83e-06	7.76e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.79e-06	7.71e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CREBBP—hematologic cancer	5.77e-06	7.69e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CD44—hematologic cancer	5.75e-06	7.66e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NQO1—hematologic cancer	5.75e-06	7.66e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.7e-06	7.6e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK3—hematologic cancer	5.65e-06	7.52e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.63e-06	7.5e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCB1—hematologic cancer	5.58e-06	7.43e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—hematologic cancer	5.49e-06	7.32e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—hematologic cancer	5.48e-06	7.3e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CD—hematologic cancer	5.47e-06	7.29e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYCS—hematologic cancer	5.44e-06	7.25e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NCOR1—hematologic cancer	5.42e-06	7.21e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—hematologic cancer	5.42e-06	7.21e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.41e-06	7.2e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—hematologic cancer	5.4e-06	7.2e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3R1—hematologic cancer	5.17e-06	6.88e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CA—hematologic cancer	5.16e-06	6.88e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTP1—hematologic cancer	5.13e-06	6.84e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KRAS—hematologic cancer	5.08e-06	6.76e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.87e-06	6.48e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.8e-06	6.39e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—hematologic cancer	4.79e-06	6.38e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CB—hematologic cancer	4.77e-06	6.35e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NCOR1—hematologic cancer	4.72e-06	6.29e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—hematologic cancer	4.72e-06	6.29e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CA—hematologic cancer	4.66e-06	6.21e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.64e-06	6.18e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.54e-06	6.05e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—hematologic cancer	4.51e-06	6.01e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.41e-06	5.87e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.41e-06	5.87e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HRAS—hematologic cancer	4.31e-06	5.75e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.22e-06	5.62e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—hematologic cancer	4.22e-06	5.62e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—hematologic cancer	4.17e-06	5.55e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—hematologic cancer	4.13e-06	5.5e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTEN—hematologic cancer	4.12e-06	5.49e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CG—hematologic cancer	4.02e-06	5.36e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—EP300—hematologic cancer	3.93e-06	5.24e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.9e-06	5.19e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—hematologic cancer	3.81e-06	5.07e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.73e-06	4.97e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.54e-06	4.71e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.5e-06	4.67e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—hematologic cancer	3.49e-06	4.65e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.43e-06	4.57e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3R1—hematologic cancer	3.34e-06	4.45e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.27e-06	4.36e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CREBBP—hematologic cancer	3.25e-06	4.33e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CB—hematologic cancer	3.08e-06	4.1e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.08e-06	4.1e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—hematologic cancer	3.04e-06	4.05e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CREBBP—hematologic cancer	3.03e-06	4.04e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.91e-06	3.87e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.91e-06	3.87e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.88e-06	3.83e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—hematologic cancer	2.84e-06	3.78e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.72e-06	3.62e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.68e-06	3.58e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTEN—hematologic cancer	2.66e-06	3.55e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—EP300—hematologic cancer	2.54e-06	3.38e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.51e-06	3.34e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—hematologic cancer	2.38e-06	3.16e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTEN—hematologic cancer	2.32e-06	3.09e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—EP300—hematologic cancer	2.21e-06	2.95e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTEN—hematologic cancer	2.17e-06	2.89e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—EP300—hematologic cancer	2.07e-06	2.75e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.88e-06	2.5e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.64e-06	2.18e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—hematologic cancer	1.53e-06	2.04e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.53e-06	2.04e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—hematologic cancer	1.34e-06	1.78e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—hematologic cancer	1.25e-06	1.66e-05	CbGpPWpGaD
